138 related articles for article (PubMed ID: 34213743)
1. Clinical, biochemical and genetic findings in adult patients with chronic hypophosphatasemia.
Guarnieri V; Sileri F; Indirli R; Guabello G; Longhi M; Dito G; Verdelli C; Corbetta S
J Endocrinol Invest; 2022 Jan; 45(1):125-137. PubMed ID: 34213743
[TBL] [Abstract][Full Text] [Related]
2. Mutational and biochemical findings in adults with persistent hypophosphatasemia.
McKiernan FE; Dong J; Berg RL; Scotty E; Mundt P; Larson L; Rai I
Osteoporos Int; 2017 Aug; 28(8):2343-2348. PubMed ID: 28401263
[TBL] [Abstract][Full Text] [Related]
3. Clinical Significance of Hypophosphatasemia in Children.
Bayramli R; Cevlik T; Guran T; Atay Z; Bas S; Haklar G; Bereket A; Turan S
Calcif Tissue Int; 2020 Jun; 106(6):608-615. PubMed ID: 32088736
[TBL] [Abstract][Full Text] [Related]
4. Relationship between bone mineral density and biochemical markers of bone turnover in hemodialysis patients.
Sit D; Kadiroglu AK; Kayabasi H; Atay AE; Yilmaz Z; Yilmaz ME
Adv Ther; 2007; 24(5):987-95. PubMed ID: 18029324
[TBL] [Abstract][Full Text] [Related]
5. Polymorphic variants of alkaline phosphatase gene correlate with clinical signs of adult hypophosphatasia?
Masi L; Marini F; Franceschelli F; Leoncini G; Cianferotti L; Cioppi F; Giusti F; Marcucci G; Gronchi G; Brandi ML
Osteoporos Int; 2021 Dec; 32(12):2461-2472. PubMed ID: 34097127
[TBL] [Abstract][Full Text] [Related]
6. Mineral bone disorder and osteoporosis in hemodialysis patients.
Slouma M; Sahli H; Bahlous A; Laadhar L; Smaoui W; Rekik S; Gharsallah I; Sallami M; Moussa FB; Elleuch M; Cheour E
Adv Rheumatol; 2020 Feb; 60(1):15. PubMed ID: 32102689
[TBL] [Abstract][Full Text] [Related]
7. Hypophosphatasia in Adults: Clinical Spectrum and Its Association With Genetics and Metabolic Substrates.
Lefever E; Witters P; Gielen E; Vanclooster A; Meersseman W; Morava E; Cassiman D; Laurent MR
J Clin Densitom; 2020; 23(3):340-348. PubMed ID: 30655187
[TBL] [Abstract][Full Text] [Related]
8. Biochemical algorithm to identify individuals with ALPL variants among subjects with persistent hypophosphatasaemia.
Tornero C; Navarro-Compán V; Buño A; Heath KE; Díaz-Almirón M; Balsa A; Tenorio JA; Quer J; Aguado P
Orphanet J Rare Dis; 2022 Mar; 17(1):98. PubMed ID: 35241128
[TBL] [Abstract][Full Text] [Related]
9. FGF23-related hypophosphatemia in patients with low bone mineral density and fragility fractures: challenges in diagnosis and management.
Indirli R; Guabello G; Longhi M; Niada S; Maruca K; Mora S; Maggioni M; Corbetta S
J Endocrinol Invest; 2020 Jun; 43(6):787-798. PubMed ID: 31863362
[TBL] [Abstract][Full Text] [Related]
10. High prevalence of osteoporosis in cardiac transplant recipients and discordance between biochemical turnover markers and bone histomorphometry.
Glendenning P; Kent GN; Adler BD; Matz L; Watson I; O'Driscoll GJ; Hurley DM
Clin Endocrinol (Oxf); 1999 Mar; 50(3):347-55. PubMed ID: 10435061
[TBL] [Abstract][Full Text] [Related]
11. Clinical, biochemical and genetic spectrum of low alkaline phosphatase levels in adults.
Riancho-Zarrabeitia L; García-Unzueta M; Tenorio JA; Gómez-Gerique JA; Ruiz Pérez VL; Heath KE; Lapunzina P; Riancho JA
Eur J Intern Med; 2016 Apr; 29():40-5. PubMed ID: 26783040
[TBL] [Abstract][Full Text] [Related]
12. Clinical, radiographic and biochemical characteristics of adult hypophosphatasia.
Schmidt T; Mussawy H; Rolvien T; Hawellek T; Hubert J; Rüther W; Amling M; Barvencik F
Osteoporos Int; 2017 Sep; 28(9):2653-2662. PubMed ID: 28547134
[TBL] [Abstract][Full Text] [Related]
13. Loss of bone mineral density in renal transplantation recipients.
Unal A; Kocyigit I; Sipahioglu MH; Tokgoz B; Kavuncuoglu F; Oymak O; Utas C
Transplant Proc; 2010 Nov; 42(9):3550-3. PubMed ID: 21094813
[TBL] [Abstract][Full Text] [Related]
14. Investigation of the common paraoxonase 1 variants with paraoxonase activity on bone fragility in Turkish patients.
Toptaş B; Kurt Ö; Aydoğan HY; Yaylim I; Zeybek Ü; Can A; Agachan B; Uyar M; Özyavuz MK; Isbir T
Mol Biol Rep; 2013 Nov; 40(11):6519-24. PubMed ID: 24057271
[TBL] [Abstract][Full Text] [Related]
15. Role of APOE Gene in Bone Mineral Density and Incidence of Bone Fractures in Brazilian Postmenopausal Women.
Souza LS; Rochette NF; Pedrosa DF; Magnago RPL; Filho TBF; Vieira FLH; Fin IDCF; Eis SR; Graceli JB; Rangel LBA; Silva IV
J Clin Densitom; 2018; 21(2):227-235. PubMed ID: 28784276
[TBL] [Abstract][Full Text] [Related]
16. Low bone mineral density and vitamin d deficiency correlated with genetics and other bone markers in female Turkish immigrants in Germany.
Tastan Y; Kann PH; Tinneberg HR; Hadji P; Müller-Ladner U; Lange U
Clin Rheumatol; 2016 Nov; 35(11):2789-2795. PubMed ID: 27034172
[TBL] [Abstract][Full Text] [Related]
17. Biochemical markers of bone turnover, endogenous hormones and the risk of fractures in postmenopausal women: the OFELY study.
Garnero P; Sornay-Rendu E; Claustrat B; Delmas PD
J Bone Miner Res; 2000 Aug; 15(8):1526-36. PubMed ID: 10934651
[TBL] [Abstract][Full Text] [Related]
18. Relationship among VDR (BsmI and FokI), COLIA1, and CTR polymorphisms with bone mass, bone turnover markers, and sex hormones in men.
Braga V; Sangalli A; Malerba G; Mottes M; Mirandola S; Gatti D; Rossini M; Zamboni M; Adami S
Calcif Tissue Int; 2002 Jun; 70(6):457-62. PubMed ID: 12016463
[TBL] [Abstract][Full Text] [Related]
19. Correlation of different bone markers with bone density in patients with rheumatic diseases on glucocorticoid therapy.
Loddenkemper K; Bohl N; Perka C; Burmester GR; Buttgereit F
Rheumatol Int; 2006 Feb; 26(4):331-6. PubMed ID: 15887044
[TBL] [Abstract][Full Text] [Related]
20. The Relevance of Osteoclastic and Osteoblastic Activity Markers Follow-Up in Patients on Antiresorptive Osteoporosis Treatment.
Smilic TN; Novakovic TR; Markovic-Jovanovic SR; Smilic LLJ; Mitic JS; Radunovic ML
J Clin Densitom; 2018; 21(3):322-328. PubMed ID: 29103946
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
